Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Fulgent Genetics, Inc. (FLGT : NSDQ)
 
 • Company Description   
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.

Number of Employees: 1,313

 
 • Price / Volume Information   
Yesterday's Closing Price: $20.06 Daily Weekly Monthly
20 Day Moving Average: 190,682 shares
Shares Outstanding: 30.44 (millions)
Market Capitalization: $610.70 (millions)
Beta: 1.03
52 Week High: $25.11
52 Week Low: $14.57
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -6.39% -10.55%
12 Week 5.58% -9.82%
Year To Date 8.61% 1.73%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4399 SANTA ANITA AVENUE
-
EL MONTE,CA 91731
USA		 ph: 626-350-0537
fax: 626-454-1667		 melanie@blueshirtgroup.com http://www.fulgentgenetics.com
 
 • General Corporate Information   
Officers
Ming Hsieh - Chief Executive Officer and Chairman
Paul Kim - Chief Financial Officer
Michael Nohaile - Director
Regina Groves - Director
Linda Marsh - Director

Peer Information
Fulgent Genetics, Inc. (HLIS)
Fulgent Genetics, Inc. (AZTA)
Fulgent Genetics, Inc. (APYI)
Fulgent Genetics, Inc. (RNVA)
Fulgent Genetics, Inc. (HMSY)
Fulgent Genetics, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 359664109
SIC: 8071
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/01/25
Share - Related Items
Shares Outstanding: 30.44
Most Recent Split Date: (:1)
Beta: 1.03
Market Capitalization: $610.70 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.53 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.91 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/01/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.54
Price/Cash Flow: -
Price / Sales: 2.09
EPS Growth
vs. Year Ago Period: 21.05%
vs. Previous Quarter: -30.43%
Sales Growth
vs. Year Ago Period: 13.92%
vs. Previous Quarter: -3.61%
ROE
06/30/25 - -
03/31/25 - -2.19
12/31/24 - -2.37
ROA
06/30/25 - -
03/31/25 - -2.02
12/31/24 - -2.18
Current Ratio
06/30/25 - -
03/31/25 - 6.32
12/31/24 - 4.85
Quick Ratio
06/30/25 - -
03/31/25 - 6.32
12/31/24 - 4.85
Operating Margin
06/30/25 - -
03/31/25 - -8.44
12/31/24 - -9.46
Net Margin
06/30/25 - -
03/31/25 - -13.94
12/31/24 - -15.07
Pre-Tax Margin
06/30/25 - -
03/31/25 - -16.93
12/31/24 - -18.33
Book Value
06/30/25 - -
03/31/25 - 36.88
12/31/24 - 36.92
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©